Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis in systemic lupus erythematosis.

Kenneth T Calamia1, Maria Balabanova

  • 1Division of Rheumatology, Mayo Clinic, Jacksonville, Florida 32224, USA. calamia.kenneth@mayo.edu

Clinics in Dermatology
|July 6, 2004
PubMed
Summary

Vasculitis is a complication in connective tissue diseases like rheumatoid arthritis and systemic lupus erythematosus (SLE), affecting about 4% of patients. Recognizing these vascular inflammatory manifestations is crucial for effective treatment and reducing patient mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synovitis due to Histoplasma capsulatum: a case series and literature review.

Rheumatology international·2021
Same author

Musculoskeletal ultrasound as a diagnostic tool for eosinophilic fasciitis and correlation with magnetic resonance imaging findings.

International journal of rheumatic diseases·2021
Same author

A boy with linear hyperpigmented atrophic plaques.

Pediatric dermatology·2020
Same author

Molecular characterization and natural history of linear porokeratosis: A case series.

Journal of the American Academy of Dermatology·2020
Same author

Intensive Multicomponent Fibromyalgia Treatment: A Translational Study to Evaluate Effectiveness in Routine Care Delivery.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2020
Same author

Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.

Acta dermatovenerologica Croatica : ADC·2020

Area of Science:

  • Rheumatology
  • Immunology
  • Pathology

Background:

  • Vasculitis is a recognized complication in connective tissue diseases (CTDs), occurring in approximately 4% of rheumatoid arthritis and systemic lupus erythematosus (SLE) cases.
  • Manifestations range from cutaneous small-vessel lesions to severe necrotizing visceral medium- and large-vessel involvement, potentially mimicking primary vasculitic syndromes.
  • CTD-associated vasculitis is distinct from primary vasculitis syndromes, with granulomatous large-vessel disease absent in CTDs, suggesting differing pathogenetic mechanisms.

Purpose of the Study:

  • To elucidate the characteristics and implications of vasculitis within the spectrum of connective tissue diseases.
  • To differentiate CTD-associated vasculitis from primary vasculitic syndromes based on clinical and pathogenetic factors.
  • To highlight the importance of recognizing vasculitic manifestations for optimizing treatment strategies and improving patient outcomes.

Related Experiment Videos

Main Methods:

  • Review of existing literature and classification schemes for vasculitis in CTDs.
  • Analysis of pathogenetic mechanisms, including the role of immune complexes and antineutrophil cytoplasmic antibodies (ANCAs).
  • Characterization of clinical features associated with arterial and venous vessel involvement across various CTDs.

Main Results:

  • Vasculitis presents with diverse clinical features due to inflammation of arteries and veins of all sizes in CTDs such as Behçet's disease and SLE.
  • Immune complexes are implicated in SLE-related inflammation, while ANCAs are less frequent compared to other vasculitides.
  • Distinguishing CTD-associated vasculitis is critical, as granulomatous large-vessel disease is not observed, indicating unique pathogenic pathways.

Conclusions:

  • Vasculitis is a significant complication in CTDs, presenting a wide range of clinical manifestations.
  • Understanding the specific pathogenetic mechanisms, such as the role of immune complexes in SLE, guides therapeutic approaches.
  • Early recognition and appropriate management of vasculitis in CTDs are essential for reducing morbidity and mortality.